Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Dec;31(3):196-200.

Next generation sequencing (NGS) strategies for the genetic testing of myopathies

Vincenzo Nigro  1 , Giulio Piluso
Affiliations

Next generation sequencing (NGS) strategies for the genetic testing of myopathies

Vincenzo Nigro et al. Acta Myol. 2012 Dec.

Abstract

Next generation sequencing (NGS) technologies offer the possibility to map entire genomes at affordable costs. This brings the genetic testing procedure to a higher level of complexity. The positive aspect is the ease to cope with the complex diagnosis of genetically heterogeneous disorders and to identify novel disease genes. Worries arise from the management of too many DNA variations with unpredictable meaning and incidental findings that can cause ethical and clinical dilemmas. The technology of enrichment makes possible to focus the sequencing to the exome or to a more specific DNA target. This is being used to provide insights into the genetics underlying Mendelian traits involved in myopathies and to set up cost-effective diagnostic tests. This huge potential of the NGS applications makes likely that these will soon become the first approach in genetic diagnostic laboratories.

Keywords: NGS; Next generation sequencing; neuromuscular disorders.

PubMed Disclaimer

References

    1. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA. 1977;74(12):5463–5467. - PMC - PubMed
    1. Metzker ML. Sequencing technologies - the next generation. Nat Rev Genet. 2009;11:31–46. - PubMed
    1. Johnston JJ, Rubinstein WS, Facio FM, et al. Secondary variants in individuals undergoing exome sequencing: screening of 572 individuals identifies high-penetrance mutations in cancer-susceptibility genes. Am J Hum Genet. 2012;91:97–108. - PMC - PubMed
    1. Mamanova L, Coffey AJ, Scott CE, et al. Target-enrichment strategies for next-generation sequencing. Nat Methods. 2010;7:111–118. - PubMed
    1. Schlipf NA, Schule R, Klimpe S, et al. Amplicon-based highthroughput pooled sequencing identifies mutations in CYP7B1 and SPG7 in sporadic spastic paraplegia patients. Clin Genet. 2011;80:148–160. - PubMed

MeSH terms

LinkOut - more resources